Measles-containing-vaccine first-dose (MCV1) immunization coverage in Germany
Germany: Measles-containing-vaccine first-dose (MCV1) immunization coverage was 96.0% in 2025. ▬ Flat
Latest (2025)
96.0%
Change on year
unchanged
World rank
42nd
of 194 countries
All-time high
98.0%
in 2021
All-time low
92.0%
in 2000
Years of data
26
2000–2025
Measles-containing-vaccine first-dose (MCV1) immunization coverage in Germany, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for measles-containing-vaccine first-dose (mcv1) immunization coverage in Germany is 96.0%, measured in 2025.
The figure is down 1.0% over ten years.
Over the whole period, measles-containing-vaccine first-dose (mcv1) immunization coverage in Germany peaked at 98.0% in 2021 and was at its lowest, 92.0%, in 2000.
That places Germany 42nd out of 194 countries with data for 2025, putting it in the top quarter.
Measles-containing-vaccine first-dose (MCV1) immunization coverage in Germany, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 92.0% | — |
| 2001 | 94.0% | +2.2% |
| 2002 | 94.0% | +0.0% |
| 2003 | 95.0% | +1.1% |
| 2004 | 96.0% | +1.1% |
| 2005 | 96.0% | +0.0% |
| 2006 | 96.0% | +0.0% |
| 2007 | 97.0% | +1.0% |
| 2008 | 97.0% | +0.0% |
| 2009 | 97.0% | +0.0% |
| 2010 | 97.0% | +0.0% |
| 2011 | 97.0% | +0.0% |
| 2012 | 97.0% | +0.0% |
| 2013 | 97.0% | +0.0% |
| 2014 | 97.0% | +0.0% |
| 2015 | 97.0% | +0.0% |
| 2016 | 97.0% | +0.0% |
| 2017 | 97.0% | +0.0% |
| 2018 | 97.0% | +0.0% |
| 2019 | 97.0% | +0.0% |
| 2020 | 97.0% | +0.0% |
| 2021 | 98.0% | +1.0% |
| 2022 | 96.0% | -2.0% |
| 2023 | 96.0% | +0.0% |
| 2024 | 96.0% | +0.0% |
| 2025 | 96.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 95.4% | 92.0% | 97.0% | 10 |
| 2010s | 97.0% | 97.0% | 97.0% | 10 |
| 2020s | 96.5% | 96.0% | 98.0% | 6 |
Countries ranked near Germany
More health data for Germany
- Un projection of annual infant deaths, annual growth rate -2.13 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.9955 % change on previous year (2090)
- Heat deaths vs projected death rates 1,164 (2090)
- Un projection of annual infant deaths 368 (2100)
- Population ages 65 and above, female, annual growth rate 1.94 % change on previous year (2025)
- Population ages 65 and above, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, female, per capita 0.1316 units per person (2025)
- Population ages 65 and above, male, annual growth rate 2.42 % change on previous year (2025)
- Population ages 65 and above, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, male, per capita 0.1054 units per person (2025)
Frequently asked questions
- What is measles-containing-vaccine first-dose (mcv1) immunization coverage in Germany?
- Measles-containing-vaccine first-dose (mcv1) immunization coverage in Germany was 96.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine first-dose (mcv1) immunization coverage recorded in Germany?
- The highest recorded value was 98.0% in 2021.
- What is the lowest measles-containing-vaccine first-dose (mcv1) immunization coverage recorded in Germany?
- The lowest recorded value was 92.0% in 2000.
- How does Germany rank for measles-containing-vaccine first-dose (mcv1) immunization coverage?
- Germany ranks 42nd out of 194 countries with data for 2025.
- Is measles-containing-vaccine first-dose (mcv1) immunization coverage rising or falling in Germany?
- Over the last ten years it is down 1.0%. The long-run trend across the full record is flat.
- Where does this Germany data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).